Safety topic
GLP-1 medications and gastroparesis (delayed gastric emptying)
Delayed gastric emptying is the deliberate mechanism of GLP-1 β that is not pathologic gastroparesis. True chronic gastroparesis after GLP-1 is rare; symptoms past week 8 at stable dose warrant evaluation.
Who should not take this
- Pre-existing severe gastroparesis (relative)
- Pre-existing severe gastrointestinal disease (relative)
How it happens
GLP-1 receptor activation delays gastric emptying as part of its therapeutic action β producing satiety and slower nutrient absorption. This is reversible on stopping the drug. True gastroparesis (chronically delayed emptying that persists off-drug) has been reported in case series but the causal attribution is debated; many cases involve pre-existing diabetes-related gastroparesis.
Red flags β when to seek care
- Severe nausea + vomiting persisting past week 8 at a stable dose
- Persistent post-meal fullness lasting hours
- Dehydration from inability to keep fluids down
What to do
- 1.Persistent severe GI symptoms past week 8 at stable dose warrants a gastric-emptying study (scintigraphy)
- 2.Discuss dose reduction or molecule switch (semaglutide β tirzepatide) with your prescriber
- 3.Stop GLP-1 immediately for persistent intractable vomiting
Affected medications
Sources
Common questions readers ask
- Can you drink alcohol on Wegovy?
- No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol β likely a secondary effect of GLP-1 on the brain reward system. Full evidence-graded answer
- Does GLP-1 affect oral birth control?
- Tirzepatide (Mounjaro, Zepbound) has documented reduced absorption of oral contraceptives during the first 4 weeks of each dose increase. Use backup contraception for ~4 weeks after starting + after each step-up. Semaglutide has no documented effect. Full evidence-graded answer
- Can I take GLP-1 while pregnant?
- No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life. Full evidence-graded answer
- Is it safe to take GLP-1 long-term?
- Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity. Full evidence-graded answer
Editorial information based on FDA prescribing data + peer-reviewed sources as of 2026. Not personal medical advice. Reviewed by Jane Novak, MD, MPH.